# animalhealthindia

> Any Animal; Any Information


## Posts

- [Maropitant Citrate - off patent but remains blockbuster for Zoetis](https://animalhealthindia.com/maropitant-citrate-off-patent-but-remains-blockbuster-for-zoetis/): Market size & scale Competitive / strategic notes Notable generic / alternative brand formulations & market players From public sources: Antiemetic comparison — veterinary use Drug (common brands) Mechanism / class Labelled status (US / EU / India) Typical dosing & frequency (dogs, general) PK notes (half-life / route) Practical notes Maropitant (Cerenia — Zoetis; generics) NK-1 (substance P) antagonist US: labelled (Zoetis Cerenia; generics approved). EU: labelled (EMA/EPAR) India: commercially available (brand & generic listings) Prevention acute vomiting: 2 mg/kg PO q24h up to 5 days. Motion sickness: 8 mg/kg PO once 2 h before travel (dogs). Injectable 1 […]
- [Size of Veterinary Monoclonal Antibodies Market and New, Upcoming Monoclonal Antibodies](https://animalhealthindia.com/size-of-veterinary-monoclonal-antibodies-market-and-new-upcoming-monoclonal-antibodies/): Market size & growth Why forecasts vary Leading companies (market participants) Leading products / brands (approved / commercial) Key market drivers Risks & constraints Regional Markets Product-level disclosed revenue (public sources) — selected mAbs Veterinary MAb pipeline — notable, not-yet-approved programs Candidate / Program Developer(s) Indication / Target Latest known stage (region) Notes / status (date) Portela (relfovetmab) Zoetis Anti-NGF for feline osteoarthritis pain (long-acting, ~3 months) Regulatory — CVMP positive opinion (EU). EC decision pending (EU). CVMP gave a positive opinion on 10 Sep 2025; EC decision expected Q4 2025 → commercial EU launch likely 2026 if authorized Licensed […]
- [Vantara Achieves Global Humane Conservation Certified™ Distinction for Animal Care, Welfare and Wellbeing](https://animalhealthindia.com/vantara-achieves-global-humane-conservation-certified-distinction-for-animal-care-welfare-and-wellbeing/): Global Humane Society, the international brand of American Humane Society, the United States’ first national humane organization and the world’s largest certifier of animal welfare practices, announced today that Vantara, a wildlife rescue and rehabilitation center in India, has earned the Global Humane Conservation Certified™ distinction for its humane standards of care and treatment of animals. Vantara has established the highest benchmark in animal welfare, rescue, rehabilitation, and conservation. Vantara is an expansive, private wildlife rescue, rehabilitation, and conservation center, spearheaded by Mr. Anant Ambani, Executive Director of the Reliance Industries. Spanning roughly 3,500 acres, it features advanced veterinary facilities such as elephant hydrotherapy, […]
- [dsm-firmenich and FarmTrace Unite to Simplify Farm-Level Sustainability Tracking](https://animalhealthindia.com/dsm-firmenich-and-farmtrace-unite-to-simplify-farm-level-sustainability-tracking/): dsm-firmenich Animal Nutrition & Health and FarmTrace, a global farm connection & analytics platform, have announced a strategic partnership to accelerate sustainable farming by removing one of the key barriers to environmental footprint measurement. The collaboration will enable direct integration of agriculture’s leading environmental footprinting solution, Sustell™, with the FarmTrace platform, significantly simplifying the collection and processing of farm-level data. By automating the ingestion of information from connected farm systems, the partnership removes the need for repeated manual inputs and complex questionnaires, empowering farmers and supply chains to scale their sustainability efforts with greater ease, speed and accuracy. David Nickell, Vice President Sustainability […]
- [Praxis Packaging acquires Advanced Concept Innovations, expands services](https://animalhealthindia.com/praxis-packaging-acquires-advanced-concept-innovations-expands-services/): Praxis Packaging Solutions (“Praxis” or the “Company”), a provider of primary and secondary contract packaging solutions for pharmaceutical, animal health, medical device, nutritional, and personal care sectors, is pleased to announce the acquisition of Advanced Concept Innovations, LLC (“ACI”). For over 35 years, Praxis has provided high-quality packaging solutions to its customers, with a commitment to quality, innovation, and customer success. The strategic combination with ACI further enhances Praxis’ customer offering by broadening Praxis’ geographic footprint into the Southeastern United States, expanding its capabilities and market segments. Located in Lakeland, Fl, ACI provides contract packaging of medical devices, over-the-counter (“OTC”), […]
- [Zoetis to declare Q3' 2025 Earnings on 4th of Nov 2025](https://animalhealthindia.com/zoetis-to-declare-q3-2025-earnings-on-4th-of-nov-2025/): Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, November 4, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review third quarter 2025 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations. Pre-registration for the webcast is available beginning today. A replay of the webcast will be made available on November 4, 2025.
- [MSD Presents Safety and Efficacy Data for Bravecto at WAAP in Brazil](https://animalhealthindia.com/msd-presents-safety-and-efficacy-data-for-bravecto-at-waap-in-brazil/): MSD Animal Health, presented multiple studies in support of the BRAVECTO® fluralaner portfolio at the 2025 World Association for the Advancement of Veterinary Parasitology Congress (WAAVP) in Curitiba, Brazil, August 17-21, 2025. Data presented highlights MSD Animal Health’s commitment to rapidly advance research across parasite prevention and treatment and build on its portfolio of established parasiticides. “The new data we presented at WAAVP spotlight our commitment to parasitology research as we develop novel treatment approaches in our ongoing work to improve parasite prevention and treatment,” said Rafael Chiummo, Ph.D., Associate Director, Clinical Research, Latin America, MSD Animal Health. “MSD Animal […]
- [CATalyst Council Releases Feline Market Insights Volume III: Continued Market Outperformance by Cats](https://animalhealthindia.com/catalyst-council-releases-feline-market-insights-volume-iii-continued-market-outperformance-by-cats/): The CATalyst Council, the veterinary industry’s leading authority on the feline market, releases the third volume of the 2025 Feline Market Insights Report, the latest in a quarterly series. In Q2 2025, while overall US clinical visits continue to fall several percent year over year, feline clinical visits continued their growth. The report updates mid-year trends, explains the economic context shaping overall veterinary visit growth, and outlines how AI innovation, Cat Friendly Practice® feline-friendly handling, clear communication, and preventive care can help close the feline care gap. Even as overall visits remain tepid, cat visits continued to climb,” said Jane Brunt, […]
- [Boehringer Ingelheim Launches VetED™ Academy, an Education Portal for Veterinary Professionals](https://animalhealthindia.com/boehringer-ingelheim-launches-veted-academy-an-education-portal-for-veterinary-professionals/): Boehringer Ingelheim today announced the launch of VetED™ Academy, a new veterinary education portal designed to streamline access to continuing education (CE) for veterinary professionals. VetED™ Academy will serve as a centralized destination for free RACE-accredited learning, consolidating content into one intuitive experience. Professional Development for Veterinarians Made Easy  Veterinarians, veterinary technicians, practice managers, clinic staff and students will be able to access RACE-accredited courses, including on-demand videos, webinars, and audio content. The content will be accessible through a single interface and will support personalized learning journeys for the veterinary community. The CE courses will also tie into the Boehringer loyalty […]
- [Global Market for Isoxazolines - Bravecto; NexGard; Simparica and Credelio](https://animalhealthindia.com/global-market-for-isoxazolines-bravecto-nexgard-simparica-and-credelio/): Isoxazolines are a novel chemical class of ectoparasiticides used in veterinary medicine. They act as systemic insecticides and acaricides by blocking ligand-gated chloride channels (γ-aminobutyric acid (GABA) and glutamate-gated channels) in invertebrates. This results in hyperexcitation and death of parasites such as fleas, ticks, and mites — while showing selective safety in mammals. They are given orally (chewables), topically, or injectable and have become the backbone of modern flea & tick control in pets. Commercialization Timeline Global Impact Isoxazoline Competitor Matrix (2024–2025) Brand Active Ingredient Company Formulations Duration of Action Spectrum / Indications 2024 Sales (approx.) Key Differentiators Bravecto Fluralaner […]
- [Honeybee Colony Collapse Linked to Virus-Infected, Miticide-Resistant Mites](https://animalhealthindia.com/honeybee-colony-collapse-linked-to-virus-infected-miticide-resistant-mites/): Project Apis m., a leading honeybee research organization focused on improving pollinator health, has recently identified the primary cause of widespread honeybee colony collapses earlier this year. According to their studies, the collapses were primarily driven by parasitic mites that are both resistant to commonly used miticides and carriers of viral infections. Supporting these findings, the USDA’s Agricultural Research Service (ARS) Bee Research Laboratory conducted extensive sampling of honeybee populations across the country. Their analyses revealed consistently high levels of deformed wing virus (DWV) types A and B, as well as acute bee paralysis virus (ABPV), in all bees recently […]
- [Scientists at NIV, India trace the source of recent Avian Influenza / Bird Flu Outbreaks](https://animalhealthindia.com/scientists-at-niv-india-trace-the-source-of-recent-avian-influenza-bird-flu-outbreaks/): Scientists at the ICMR-National Institute of Virology (NIV) published their recent findings on the origins and genetic evolution of avian Influenza virus, isolated from recent outbreaks in India. In their recent findings published in Virology (Elsevier), scientists have shown that the strains of avian influenza / bird flu seen in Kerala in 2024 are likely of East Asian origin. Key Findings Implications
- [Sai Life Sciences Opens Veterinary-API Facility in Bidar to Meet Rising Animal Health Demand; Competition for Incumbents](https://animalhealthindia.com/sai-life-sciences-opens-veterinary-api-facility-in-bidar-to-meet-rising-animal-health-demand-competition-for-incumbents/): Sai Life Sciences, a leading contract research, development, and manufacturing organization (CRDMO), has inaugurated Unit VI, a new dedicated veterinary active pharmaceutical ingredient (API) manufacturing facility at Bidar, Karnataka. The site is positioned adjacent to the company’s flagship API campus, reinforcing Sai’s growing presence in animal health manufacturing and offering global veterinary drug sponsors a purpose-built platform for API supply. Dedicated Focus on Veterinary APIs The establishment of Unit VI underscores the increasing recognition that animal health APIs require specialized infrastructure, regulatory pathways, and operational standards distinct from those of human pharmaceuticals. With demand for veterinary medicines continuing to rise—driven […]
- [Punjab acts on growing risk of AMR, rolls out New Measures](https://animalhealthindia.com/punjab-acts-on-growing-risk-of-amr-rolls-out-new-measures/): In response to the growing threat posed by antimicrobial resistance (AMR), the Punjab government has announced a sweeping set of measures aimed at restricting the misuse of antibiotics and preserving their effectiveness. Under the newly launched state action plan, officials intend to ban the over-the-counter (OTC) sale of certain classes of antibiotics and impose stricter regulatory control on their prescription, distribution, and environmental disposal. What the Plan Includes Why the Move Challenges Anticipated Expected Impact If successful, the policy could lead to:
- [ZyVet Animal Health Expands Portfolio with First FDA-Approved Generic Phenylpropanolamine Hydrochloride Tablets for Dogs](https://animalhealthindia.com/zyvet-animal-health-expands-portfolio-with-first-fda-approved-generic-phenylpropanolamine-hydrochloride-tablets-for-dogs/): ZyVet Animal Health, a leader in affordable generic pharmaceuticals for companion animals and a wholly owned subsidiary of Zydus Pharmaceuticals (USA), has announced the launch of the first FDA-approved generic phenylpropanolamine hydrochloride tablets. This product provides veterinarians and pet owners with a trusted and cost-effective treatment for managing urinary incontinence in dogs, a condition that significantly impacts the well-being of pets and their families. This milestone reflects ZyVet’s commitment to its core mission: delivering safe, effective, and accessible therapies that help veterinary professionals provide high-quality care without financial barriers. Addressing an Important Medical Need in Companion Animals Phenylpropanolamine hydrochloride has […]
- [Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats](https://animalhealthindia.com/zoetis-receives-positive-opinion-from-cvmp-for-portela-relfovetmab-to-alleviate-pain-associated-with-osteoarthritis-in-cats/): Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of marketing authorization for Portela® (relfovetmab), a new monoclonal antibody (mAb) therapy intended for the alleviation of pain associated with osteoarthritis (OA) in cats. Portela Will Be First Long-Acting Anti-NGF mAb Therapy for Cats, If ApprovedIf approved, Portela will be the first long-acting anti-nerve growth factor (NGF) mAb therapy for cats and is designed to provide three months of osteoarthritis (OA) pain relief with a single injection. The product targets NGF, a key mediator of OA pain. The CVMP has recommended […]
- [First there was 1 and Now 3 – Evolution of JAK-Inhibitors in Pet Dermatology](https://animalhealthindia.com/first-there-was-1-and-now-3-evolution-of-jak-inhibitors-in-pet-dermatology/): JAK inhibitors are immune-modulating medications that target the JAK-STAT signaling pathway, which plays a key role in inflammatory diseases like atopic dermatitis. By blocking Janus kinase (JAK) enzymes, these drugs interfere with the transmission of inflammatory signals from immune cells, helping to calm the overactive immune system and reduce inflammation, itching, and eventually self-inflicted, skin lesions in pets.  Following the lead in Human Health where these JAK Inhibitors were already commercialized, Animal Health Industry witnessed the regulatory approval of 1st JAK-Inhibitor, with the launch of Apoquel® (oclacitinib maleate), way back in January 2014. JAK-Inhibitors’ have a unique and innovative mode of […]
- [Targeting a Silent Killer: UConn Researcher Patents Leptospirosis Vaccine](https://animalhealthindia.com/targeting-a-silent-killer-uconn-researcher-patents-leptospirosis-vaccine/): Elsio Wunder, assistant professor of pathobiology and veterinary science in the College of Agriculture, Health and Natural Resources (CAHNR), has filed a patent for a vaccine against leptospirosis that uses a unique combination of highly conserved proteins. This filing represents Wunder moving one step closer to developing a universal vaccine for leptospirosis, a widely neglected disease. Last year, Wunder received a $3.8 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) to pursue this goal. Leptospirosis is a bacterial infection that causes flu-like symptoms and can be life-threatening. Leptospirosis causes an estimated 60,000 human deaths a year. The disease is spread through contact […]
- [WSU researchers join $9.6M push to fight Rift Valley Fever- a potential zoonotic disease](https://animalhealthindia.com/wsu-researchers-join-9-6m-push-to-fight-rift-valley-fever-a-potential-zoonotic-disease/): A two-year, $9.6 million effort led in part by Washington State University will help provide a better understanding of the spread and impact of the deadly Rift Valley fever virus in Africa and to prepare for upcoming human clinical trials. Rift Valley fever is a mosquito-borne illness that can cause severe sickness and death in humans, and it is particularly devastating to livestock herds. Outbreaks have been consistently linked with intense periods of rainfall and flooding, which promotes mosquito breeding and hatching. First identified in East Africa’s Rift Valley in 1930, outbreaks are becoming more frequent and are spreading into new areas […]
- [Renaissance BioScience secures Australian Patent for novel, RNA Technology with applications in Animal Health Parasitology](https://animalhealthindia.com/renaissance-bioscience-secures-australian-patent-for-novel-rna-technology-with-applications-in-animal-health-parasitology/): Renaissance BioScience Corp. has recently been granted another patent for its innovative yeast-based platform technology for the low-cost production and effective delivery of RNA. The new patent, awarded by the Australian patent office, is the second patent awarded for this RNA technology IP, with more jurisdictions pending. The first patent was awarded by China. This Australian patent joins the company’s extensive IP portfolio of issued and pending patents for multiple end-use markets.  Renaissance’s most commercially advanced application of its yeast-based RNA production and delivery system is a suite of RNAi-based biopesticide products designed for a precise, targeted approach to pest […]
- [Gallant introduces GallantU: CE Platform Preparing Veterinary Professionals for Pet Stem Cell Therapy](https://animalhealthindia.com/954-2/): Gallant, an animal health biotechnology company pioneering ready-to-use stem cell therapies for pets, announced the launch of its proprietary online continuing education (CE) platform, GallantU. Built with general practitioners in mind, GallantU represents a significant step forward in veterinary education – offering a comprehensive training programme to help veterinary professionals lead confidently in the regenerative medicine era. GallantU courses cover the science, clinical use, and future potential of allogeneic, ready-to-use stem cell therapy – a new class of drugs actively explored for their ability to modulate immune responses, reduce inflammation, and help restore health at the source. By addressing the root […]
- [Zenrelia - becomes 3rd available JAK Inhibitor on Steady Growing Pet Derma Market](https://animalhealthindia.com/zenrelia-becomes-3rd-available-jak-inhibitor-on-steady-growing-pet-derma-market/): Zenrelia, an effective, convenient, and safe once-daily oral JAK inhibitor, continues its launch progress globally, gaining approval from the United Kingdom’s Veterinary Medicines Directorate in August 2025. Additionally, launch progress continues across the EU and Great Britain with product supply now in market for veterinarians and pet owners. “Now we have a medication that is once a day right from the start. I think it will really help improve that owner, patient, pet bond, it will hopefully help reduce caregiver burden and will improve patient and carer quality of life as well,” said Dr. Victoria Robinson BVM&S, BSc, CertAVP (VD), DipECVD, […]
- [Credelio Quattro attains Blockbuster Status within 8 months of Launch](https://animalhealthindia.com/credelio-quattro-attains-blockbuster-status-within-8-months-of-launch/): Credelio Quattro – which is currently approved and launched only in USA attained the status of blockbuster by notching revenues of USD 100 Million within 8 months of its launch. 100 Million Revenue is the hurdle for attaining Blockbuster Status in Animal Health Industry compared to Human Parma wherein the similar status is attained post sales revenues of USD 1 Billion. Credelio Quattro – a combination of lotilaner, moxidectin, praziquantel and pyrantel – became Elanco’s fastest pet health blockbuster in its history and one of the industry’s fastest ever, especially with a single geographic approval, reaching blockbuster status of $100 […]
- [Auto-ship Powers Chewy's Revenues in Q2' 2025; Representing 83% of Quarterly Sales](https://animalhealthindia.com/auto-ship-powers-chewys-revenues-in-q2-2025-representing-83-of-quarterly-sales/): Chewy remains one of the most trusted and convenient destination for pet parents and partners everywhere as evidenced by its Q2’ 2025 revenues announced recently. Chewy – a preeminent online source for pet products, supplies, and prescriptions in USA, remain market leader on account of its broad selection of high-quality products and services, offered at competitive prices and delivered with an exceptional level of care, and a personal touch to build brand loyalty and drive repeat purchasing. Chewy has sewn partnerships with around 3,200 of the best and most trusted brands in the pet industry, apart from its own private […]
- [CVMP - New Products Approvals and Variation Approvals in July 2025](https://animalhealthindia.com/cvmp-new-products-approvals-and-variation-approvals-in-july-2025/): Approval of New Products by CVMP The Committee foe Veterinary Medicinal Products in its recently concluded meeting, adopted by consensus a positive opinion for a marketing authorisation from Axience for Hemosyvet(etamsylate) for prevention and treatment of surgical, post traumatic, obstetric and gynaecological haemorrhages in cattle, sheep, goats, pigs, horses, dogs and cats. The Committee adopted by consensus a positive opinion for a marketing authorisation from FILAVIE for Cevac REOMUNE for passive immunisation of broilers induced by active immunisation of broiler breeders to reduce clinical signs of tenosynovitis induced by avian reovirus infection. Variation Approvals for Existing Products The Committee adopted by consensus a positive opinion for a variation requiring assessment […]
- [Librela - 1st approved MAb in Dogs, under safety review by CVMP](https://animalhealthindia.com/librela-1st-approved-mab-in-dogs-under-safety-review-by-cvmp/): Librela (bedinvetmab injection) from Zoetis was first approved by CVMP – Committee for Veterinary Medicinal Products, European Union in September 2020 and was subsequently approved by US FDA in May 2023, for the control of pain associated with osteoarthritis (OA) in dogs. Librela was the first monoclonal antibody (mAb) approved for use in dogs. This approval followed the approval of a first MAb ever, again developed by Zoetis, for usage in any animal species, a mAb for cats, which was the first mAb new animal drug approved by the FDA for the control of pain associated with OA in cats. […]
- [Carabeef Exports from India in 2024](https://animalhealthindia.com/carabeef-exports-from-india-in-2024/): According to data from the Agricultural and Processed Food Products Export Development Authority (APEDA), India’s buffalo meat exports for the 2023–2024 fiscal year (April to March) were valued at $3.74 billion. This was an increase over the previous year. This made India one of the largest bovine meat exporters in the world.  Export value and volume for FY 2024 Key trends in 2024 Major export destinations in 2024 Indian buffalo meat is shipped to over 70 countries, with major markets in Southeast Asia and the Middle East. Key destinations include:  Top 10 exporters from India, in 2024 Here is the list […]
- [As India undertakes GST Reforms - Poultry Industry Requests for Reprieve in GST Rates](https://animalhealthindia.com/as-india-undertakes-gst-reforms-poultry-industry-requests-for-reprieve-in-gst-rates/): Poultry industry has appealed to the government to abolish 5% GST on frozen chicken and to reduce from 12% to 5% GST on value added poultry products – The Indian poultry industry has been witnessing a sustained growth rate of around 8% in the last decade as the industry has been able to provide nutritional requirements of a large mass of people at an affordable cost. The poultry industry also helps maize and soybean (meal is the by-product used in the feed) farmers in getting remunerative prices because of rising demand of animal feed over the years. Over 92% of […]
- [Animal Health Drug Approvals by US FDA till July 2025](https://animalhealthindia.com/animal-health-drug-approvals-by-us-fda-till-july-2025/): Date Application Number Sponsor Product Name Species July 21, 2025 200-817 Felix Pharmaceuticals Pvt. Ltd. Meloxicam Oral Suspension  Dogs July 18, 2025 200-759 ZyVet Animal Health, Inc.  Furosemide Tablets Dogs and Cats July 17, 2025 141-607 Intervet, Inc.  Exzolt™ (fluralaner oral solution)  Chickens, laying hens and replacement chickens July 11, 2025 200-816 Cronus Pharma Specialities India Private Ltd. Meloxisol™(meloxicam oral suspension) Dogs July 10, 2025 141-599 Intervet, Inc. BRAVECTO® QUANTUM(fluralaner for extended-release injectable suspension) Dogs July 8, 2025  200-815 Felix Pharmaceuticals Pvt. Ltd. Cefpodoxime Proxetil Tablets Dogs July 8, 2025 200-808 Huvepharma EOOD MGA® and Experior™ and Monovet® and Tylovet®(melengestrol […]
- [Global AH Vaccines Market 2024-2029](https://animalhealthindia.com/global-ah-vaccines-market-2024-2029/): The veterinary vaccines industry is entering a high-growth phase, fueled by a surge in companion animal ownership, rising zoonotic disease risks, and strong government initiatives in animal health. This momentum signals massive opportunities for innovation, scalability, and leadership in the sector. Market Stats & Strategic Insights: Global Veterinary Vaccines Market was at USD 8.93 Billion in CY 2023, growing to USD 9.39 Billion in CY 2024 and is projected to reach USD 13.33 billion by 2029, up from USD 9.39 billion in 2024. Steady CAGR of 6.1% reflects sustained demand and innovation and a growth in line with overall growth […]
- [India's Pharmaceuticals Exports and Imports - Q1' 2025](https://animalhealthindia.com/indias-pharmaceuticals-exports-and-imports-q1-2025/): India – famous for being Pharmacy to the World, has recorded a modest 5.2% growth in exports in Q1 of the ongoing New Financial Year 2025-26. Pharmaceutical Exports amounted to USD  $7.57 billion in the first quarter of the current financial year compared with the corresponding quarter of the previous fiscal. India’s Exports Basket Mr. Namit Joshi, Chairman of Phramexcil (Pharmaceuticals Exports Promotion Council) stated that Indian Pharmaceutics continue to solidify pivotal role in Global Healthcare space despite the expected setback from a threat of increased Trump Tariffs in the coming months. Formulations and Biologics constitute more than 75% of […]
- [India's Poultry Industry - Past Perfect; Future Tense](https://animalhealthindia.com/indias-poultry-industry-past-perfect-future-tense/): Overview of India’s Poultry Sector India is a global leader in poultry production:  Poultry Population 2024:  Feed Consumption Poultry Products Consumption in IndiaPer capita consumption in India currently averages: Future Expectations and Growth Projections By 2025-26, estimates suggest:  Chicken Feed Components’ requirements will rise to:  The Central Role of Maize Maize forms the backbone of poultry feed, contributing to over 70% of the feed composition. Its role is crucial not just for growth but also for enhancing the quality of eggs and meat. However, maize is now also being diverted to other sectors, notably: Projections for maize demand and production: 2025-26  2030-31:  The gap […]
- [India puts a decent show of Seafood Exports in 2024-25, under shadow of Upcoming Trump Tariffs](https://animalhealthindia.com/india-puts-a-decent-show-of-seafood-exports-in-2024-25-under-shadow-of-upcoming-trump-tariffs/): Under the looming threat of Trump Tariffs coming into effect from August 27, 2025, Marine Products Export Development Authority (MPEDA) of India released performance data for FY 2024-25 ending March 2025. India exported a total of around 1.7 million metric tons of seafood worth USD $7.45 billion during recently concluded financial year 2024-25, with as usual frozen shrimp continuing to retain biggest pie of India’s seafood exports. As in FY 2023-24, in the just concluded FY of 2024-25, USA maintained its top spot as the major buyer for Indian seafood followed closely by PR China.   Value – USD Billion […]
- [Governor discusses ASF Situation in Mizoram, India](https://animalhealthindia.com/governor-discusses-asf-situation-in-mizoram-india/): Mizoram Governor General (Dr) Vijay Kumar Singh, PVSM, AVSM, YSM (Retd) today held meeting with senior officials of the Animal Husbandry and Veterinary (A.H. & Vety.) Department, led by Secretary Pu Lalsangliana, at Raj Bhavan to address the ongoing African Swine Fever (ASF) crisis in the state. Governor General (Dr) Vijay Kumar Singh expressed grave concern over the devastating impact of ASF, which has caused significant economic losses and disrupted livelihoods across Mizoram for the past four years. Highlighting the department’s limited capacity to manage the outbreak independently, he called for enhanced collaboration with other government departments and increased public […]
- [African Swine Fever (ASF) situation update in Asia & Pacific Source, Credits - FAO](https://animalhealthindia.com/african-swine-fever-asf-situation-update-in-asia-pacific-source-credits-fao/): Overview Hazard: African swine fever (ASF) is a viral disease affecting pigs and wild boar with up to 100% case fatality rate. ASF reported countries since August 2018: China, Mongolia, Viet Nam, Cambodia, Democratic People’s Republic of Korea, Lao People’s Democratic Republic, Myanmar, The Philippines, Republic of Korea, Timor-Leste, Indonesia, Papua New Guinea, India, Malaysia, Bhutan, Thailand, Nepal, Singapore, Bangladesh and Sri Lanka. Notes: Dotted line represents approximately the Line of Control in Jammu and Kashmir agreed upon by India and Pakistan. The final status of Jammu and Kashmir has not yet been agreed upon by the parties.Source: United Nations Geospatial. 2020. Map […]
- [BiomEDIT - a specialty Animal Health Microbiome Company secures Series B Funding](https://animalhealthindia.com/biomedit-a-specialty-animal-health-microbiome-company-secures-series-b-funding/): Poultry industry’s first engineered probiotic biologic moves into final development and regulatory stages for USDA conditional licensure and commercial scale-up BiomEdit, a pioneering animal health biotechnology company, recently announced a significant milestone in the development of BE-101, its lead candidate for the prevention of mortality associated with necrotic enteritis (NE) in broiler chickens. The product has entered the final phase of the U.S. Department of Agriculture’s (USDA) conditional licensure process and is advancing toward commercialization, expected in 2026. BE-101, which will assume the brand name “Optavant™” upon full licensure, is the first-of-its-kind probiotic vectored antibody (pvAb™) product designed to neutralize Clostridium perfringens toxins – the major cause of NE associated productivity losses, disease and mortality, offering poultry producers a powerful, […]
- [Elanco shines in Q2' 2025 Earnings Show](https://animalhealthindia.com/elanco-shines-in-q2-2025-earnings-show/): Elanco Animal Health seems finally turning the corner what with its much touted Innovation Portfolio contributing to Revenue Growth and bolstering its profitability. Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the second quarter of 2025, provided guidance for the third quarter of 2025, and updated guidance for the full year 2025. Select Business Highlights Since the Last Earnings Call
- [Is Zoetis Losing its 'Mojo' - Analysis of Q2' 2025](https://animalhealthindia.com/is-zoetis-losing-its-mojo-analysis-of-q2-2025/): Zoetis’s Q2 2025 earnings report revealed a mixed performance, leading to analyst adjustments and a drop in its share prices. While the company surpassed analyst expectations on revenue and EPS, concerns about certain product lines, particularly within the livestock segment and the monoclonal antibody (mAb) products for osteoarthritis (OA) pain, raised questions about the company’s competitive advantage (or “moat”). UBS became one of the first ones to lower the price target for Zoetis to a modest USD 165 not very far from the current stock price of USD 154 as on close of 15th of August 2025. Here’s a closer look […]
- [Jaguar Animal Health - Net Q2 2025 Revenue Up 35% sequentially](https://animalhealthindia.com/jaguar-animal-health-net-q2-2025-revenue-up-35-sequentially/): Jaguar Animal Health Sales Up 35% in Q2′ 2025 Over Q1′ 2025 2025 SECOND QUARTER COMPANY FINANCIAL RESULTS:
- [Venkys India bears the brunt of lower broiler prices and muted demand in its Q1' FY 2025-26 Sales Revenues](https://animalhealthindia.com/venkys-india-bears-the-brunt-of-lower-broiler-prices-and-muted-demand-in-its-q1-fy-2025-26-sales-revenues/): India’s leading poultry integrator, Venky’s India witnessed the impact of demand slowdown and prevailing lower prices of broiler chickens in its recently announced Sales and Earnings for Q1′ 2025-26. Venkys India posted a near 79 per cent drop in its first-quarter profit on Friday, impacted by shrinking poultry business margins shrank, on account of over-supply of broiler chickens and muted market demand leading to lower price realizations. The poultry major reported a net profit of ₹15.83 crore ($1.81 million) in the quarter ended June 30, compared to last year’s ₹75.18 crore ($8.85 million) in the same period. India’s poultry industry […]
- [BinSentry Raises $50 Million to Modernize Animal Feed Supply Chains with AI-Powered Sensor Technology](https://animalhealthindia.com/binsentry-raises-50-million-to-modernize-animal-feed-supply-chains-with-ai-powered-sensor-technology/): Kitchener, Ont., and Austin, Texas, August 11, 2025 – Lead Edge Capital backs BinSentry’s cutting-edge sensor technology and software platform as the global agriculture industry moves toward automation and precision-driven solutions. Investment comes as BinSentry expands global footprint and agriculture industry seeks smarter, more cost-effective ways to streamline feed operations and improve profitability. BinSentry, a technology company helping major agriculture enterprises optimize feed supply chains through AI-powered sensors and real-time monitoring, today announced a $50 million Series C funding round led by Lead Edge Capital. This investment will support the acceleration of BinSentry’s global expansion, following a year of extraordinary performance and growth. […]
- [Veko Care - India's Leading Companion Animals Products Manufacturer is now EU GMP Certified](https://animalhealthindia.com/veko-care-indias-leading-companion-animals-products-manufacturer-is-now-eu-gmp-certified/): Veko Care , India’s leading contract manufacturer of Animal Health Products, founded in 2018 has recently achieved European Union’s Good Manufacturing Practices (EU GMP) certification, thus opening up significant opportunities to expand its reach globally. EU GMP Certification would allow Veko Care to access semi-regulated and even regulated markets for 8 different dosage forms and sets up the company to further grow its global presence. India is emerging as a reliable supplier of high quality animal health products following in foot steps of larger human pharmaceutical companies who have solidified India’s reputation as Pharmacy to the World. Veko Care currently […]
- [Genetic Test Now Available to Test CKD in Cats](https://animalhealthindia.com/genetic-test-now-available-to-test-ckd-in-cats/): PULLMAN, Wash. — With a swab of their cat’s cheek, pet owners can now determine if their cat is at high risk of developing one of the most common chronic diseases years before any clinical signs emerge, and it could allow them to take measures to prolong their cat’s life. The advancement is made possible by a genetic test that detects predisposition to progressive chronic kidney disease that has been developed by veterinarians at Washington State University’s College of Veterinary Medicine. The test, known as Feline Apoptosis Inhibitor Macrophages, or FAIM, will be available to veterinarians and cat owners. Chronic […]

## Pages

- [Market Reports](https://animalhealthindia.com/market-reports/)
- [Home](https://animalhealthindia.com/)
- [Login/Register](https://animalhealthindia.com/tds-login-register/)
- [My account](https://animalhealthindia.com/tds-my-account/)
- [Checkout](https://animalhealthindia.com/tds-checkout/)
- [CORPORATE NEWS](https://animalhealthindia.com/corporate-news/)
- [EXOTIC BIRDS](https://animalhealthindia.com/exotic-birds/)


[comment]: # (Generated by Hostinger Tools Plugin)